PTEN, a direct target gene of this miRNA, is significantly downregulated in drug-resistant breast cancer cells, and restoration of PTEN expression blocks miR-21-induced EMT and gemcitabine resistance [139]. The gene discussed is PTEN; the disease is breast carcinoma.